|
| Discovery gets approvable letter for respiratory drug |
7 May 08, 12:38 |
|
| Discovery Laboratories, Inc. has received an Approvable Letter from the US Food and Drug Administration (FDA) for Surfaxin (lucinactant) for the prevention of Respiratory Distress Syndrome (RDS) in premature infants. |
| more |
|
